Protocol No.: PB-102-F20

Title
A Randomized, Double blind, Active Control Study of the Safety and Efficacy of PRX-102 compared to Agalsidase Beta on Renal Function in Patients with Fabry Disease Previously Treated With Agalsidase Beta
Principal Investigator
Narumanchi, TaraChandra
Phase
III
Age Group
Both
Applicable Disease Site
Other Conditions/Diseases
Participating Institution
Health Sciences Center
Contacts